We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Synthace and Ipsen Partner to Accelerate Novel Therapeutic Development Through Automation

Product News   Nov 05, 2020

 
Synthace and Ipsen Partner to Accelerate Novel Therapeutic Development Through Automation
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Porvair Reports Ovarian Cancer Project Shows Promise

Product News

Porvair Sciences reports it has agreed with its collaborative partners to make additional investment in the CEAT project.

READ MORE

FairJourney Biologics enters antibody discovery agreement with Pandion Therapeutics

Product News

FairJourney Biologics S.A (FJB) and IONTAS Limited (IONTAS) today announced they have signed an agreement to discover antibodies with Pandion Therapeutics (Pandion).

READ MORE

BioVersys Announces First Subjects Dosed in Phase 1 Clinical Trial of BV100

Product News

BioVersys has reached a major milestone by entering clinical development with the start of Phase 1 testing of BV100 in healthy volunteers.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE